Bacteraemic pneumococcal disease in a teaching hospital in Finland

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 41-46

  Lääveri, Tinja ^a   Nikoskelainen, Jukka ^a   Meurman, Olli ^c   Eerola, Erkki ^b   Kotilainen, Pirkko ^a,c,d  

^a Turku University   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL ABUSE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CREATININE BLOOD LEVEL; FEMALE; FINLAND; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RESPIRATORY FAILURE; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; TEACHING HOSPITAL; THROMBOCYTOPENIA;

EID: 0029871041     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027148     Document Type: Article

References (32)

1. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia, JAMA 249: 1055-57, 1983.
2. Ruben FL, Norden CW, Korica Y. Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am J Med 77: 1091-1094, 1984.
3. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J 290: 505-508, 1985.
4. Siegman-Igra Y, Schwartz D, Alperin H, Konforti N. Invasive pneumococcal infection in Israel. Review of 90 cases. Scand J Infect Dis 18: 511-517, 1986.
5. Bruyn GA, van der Meer JWM, Hermans J, Knoppert W. Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden. Rev Infect Dis 10: 446-450, 1988.
6. Jette LP, Lamothe F, and the Pneumococcus Study Group. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 27: 1-5, 1989.
7. Bruyn GAW, Kremer HPH, de Marie S, Padberg GW, Hermans J, van Furth R. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur J Clin Microbiol Infect Dis 8: 695-700, 1989.
8. Davidson M, Schraer CD, Parkinson AJ, Campbell JF, Facklam RR, Wainwright RB, Lanier AP, Heyward WL. Invasive pneumococcal disease in an Alaska native population, 1980 through 1986. JAMA 261: 715-718, 1989.
9. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina, a decade later. Arch Intern Med 150: 1401-1405, 1990.
10. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 24: 247-255, 1992.
11. Örtqvist Å, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis 20: 163-171, 1988.
12. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 7: 133-142, 1985.
13. Kuikka A, Syrjänen J, Renkonen O-V, Valtonen W. Pneumococcal bacteraemia during a recent decade J Infect 24: 157-168, 1992.
14. National Committee for Clinical Laboratory Standards. Approved standard M7A2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Vilianova, Pa., 1990.
15. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumbacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 94: 505-518, 1981.
16. Örtqvist Å, Kalin M, Julander I, Mufson MA. Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations - Huntington, WVa, and Stockholm, Sweden. Chest 103: 710-716, 1993.
17. Gruer LD, McKendrick MW, Geddes AM. Pneumococcal bacteraemia - a continuing challenge. Q J Med 210: 259-270, 1984.
18. Gillespie SH. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J Med Microbiol 28: 237-248, 1989.
19. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14: 801-809, 1992.
20. Nielsen SV, Henrichsen J Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983-1988. Scand J Infect Dis 25: 165-170, 1993.
21. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60: 759-776, 1964.
22. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 134: 505-509, 1974.
23. Perlino C, Rimland A. Alcoholism, leukopenia and pneumococcal sepsis. Am Rev Respir Dis 132: 757-760, 1985.
24. Beytout J, Bernard E, Stahl J, Blanc D, Beuscart C. Fatal septicemias: factors of mortality. Analysis of 72 fatal cases in the series of 462 case reports collected by the Septicemia Expert System group in 1985. Pathol Biol 35: 819-824, 1987.
25. Woodhead MA, MacFarlane JT, Rodgers FG, Laverick A, Pilkington R, Macrae AD. Aetiology and outcome of severe community-acquired pneumonia. J Infect 10: 204-210, 1985.
26. Lehtonen O-P. Inhibition of Pneumococcal autolysis in lysis-centrifugation blood culture. J Clin Microbiol 24: 493-494, 1986.
27. Kellogg JA, Bankert DA, Manzella JP, Parsey KS, Scott SL, Cavanaugh SH. Clinical comparison of isolator and thiol broth with ESP aerobic and anaerobic bottles for recovery of pathogens from blood. J Clin Microbiol 32: 2050-2055, 1994.
28. Carey RB. Clinical comparison of the Isolator 1.5 microbial tube and the BACTEC radiometric system for detection of bacteremia in children. J Clin Microbiol 19: 634-638, 1984.
29. Alvarez S, Guarderas J, Shell CG, Holtsclaw-Berk S, Berk SL. Nosocomial pneumococcal bacteremia. Arch Intern Med 146: 1509-1512, 1986.
30. Recommendations of the Immunization Practices Advisory Committee: pneumococcal polysaccharide vaccine. MMWR 38: 64-76, 1989.
31. Mäkelä PH, Jokinen C, Pyhälä R, Mäkelä M, Ruutu P. Use of vaccines for respiratory infections. Strategies for influenza and pneumococcal vaccines. Scand J Infect Dis Suppl 70: 141-148, 1990
32. Broome CV, Breiman RF. Pneumococcal vaccine - past, present, and future. N Engl J Med 325: 1506-1508, 1991.